Back to Search
Start Over
Potential role of probiotics in reducing Clostridioides difficile virulence: Interference with quorum sensing systems.
- Source :
-
Microbial Pathogenesis . Apr2021, Vol. 153, pN.PAG-N.PAG. 1p. - Publication Year :
- 2021
-
Abstract
- Opportunistic pathogenic bacteria may cause disease after the normally protective microbiome is disrupted (typically by antibiotic exposure). Clostridioides difficile is one such pathogen having a severe impact on healthcare facilities and increasing costs of medical care. The search for new therapeutic strategies that are not reliant on additional antibiotic exposures are currently being explored. One such strategy is to disrupt the production of C. difficile virulence factors by interfering with quorum sensing (QS) systems. QS has been well studied in other bacteria, but our understanding in C. difficile is not so well understood. Some probiotic strains or combinations of strains have been shown to be effective in the treatment or primary prevention of C. difficile infections and may possess multiple mechanisms of action. One mechanism of probiotics might be the inhibition of QS, but their role has not been clearly defined yet. A literature search was conducted using standard databases (PubMed, Google Scholar) from database inception to August 2020. The objective of this paper is to update our understanding of how QS leads to toxin production by C. difficile , which is important in pathogenesis, and how QS inhibitors or probiotics may disrupt this pathway. We found two main QS systems for C. difficile (Agr and Lux systems) that are involved in C. difficile pathogenesis by regulating toxin production, motility and adherence. Probiotics and other QS inhibitors targeting QS systems may represent important new directions of therapy and prevention of CDI. • Two quorum sensing (QS) systems (Lux and Agr) have been discovered to regulate C. difficile virulence factors. • QS inhibitors and quorum quenching enzymes play a role in interfering with the production of virulence factors regulated by QS systems. • Another mechanism of action for some probiotics involve inhibition of the QS system. • Probiotics targeting QS of C.difficile represent an innovative therapy and prevention strategy for CDI. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 08824010
- Volume :
- 153
- Database :
- Academic Search Index
- Journal :
- Microbial Pathogenesis
- Publication Type :
- Academic Journal
- Accession number :
- 149571076
- Full Text :
- https://doi.org/10.1016/j.micpath.2021.104798